84 related articles for article (PubMed ID: 25104332)
1. Diabetes and breast cancer in Taiwanese women: a detection bias?
Tseng CH
Eur J Clin Invest; 2014 Oct; 44(10):910-7. PubMed ID: 25104332
[TBL] [Abstract][Full Text] [Related]
2. Type 2 Diabetes Mellitus and Kidney Cancer Risk: A Retrospective Cohort Analysis of the National Health Insurance.
Tseng CH
PLoS One; 2015; 10(11):e0142480. PubMed ID: 26559055
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer incidence before and after diagnosis of type 2 diabetes mellitus in women: increased risk in the prediabetes phase.
Onitilo AA; Stankowski RV; Berg RL; Engel JM; Glurich I; Williams GM; Doi SA
Eur J Cancer Prev; 2014 Mar; 23(2):76-83. PubMed ID: 23571511
[TBL] [Abstract][Full Text] [Related]
4. New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer.
Tseng CH
Pancreas; 2013 Jan; 42(1):42-8. PubMed ID: 22750971
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone and oral cancer risk in patients with type 2 diabetes.
Tseng CH
Oral Oncol; 2014 Feb; 50(2):98-103. PubMed ID: 24239280
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
[TBL] [Abstract][Full Text] [Related]
7. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
[TBL] [Abstract][Full Text] [Related]
8. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
Tseng CH
BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
[TBL] [Abstract][Full Text] [Related]
9. Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan.
Tseng CH
Eur J Endocrinol; 2012 Sep; 167(3):409-16. PubMed ID: 22778198
[TBL] [Abstract][Full Text] [Related]
10. Prediabetes, diabetes, and risk of breast cancer: a case-control study.
Salinas-Martínez AM; Flores-Cortés LI; Cardona-Chavarría JM; Hernández-Gutiérrez B; Abundis A; Vázquez-Lara J; González-Guajardo EE
Arch Med Res; 2014 Jul; 45(5):432-8. PubMed ID: 24937172
[TBL] [Abstract][Full Text] [Related]
11. Diabetes, insulin use, and gastric cancer: a population-based analysis of the Taiwanese.
Tseng CH
J Clin Gastroenterol; 2013 Jul; 47(6):e60-4. PubMed ID: 23269314
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin receptor blockade and risk of cancer in type 2 diabetes mellitus: a nationwide case-control study.
Chang CH; Lin JW; Wu LC; Lai MS
J Clin Oncol; 2011 Aug; 29(22):3001-7. PubMed ID: 21690476
[TBL] [Abstract][Full Text] [Related]
14. Diabetes is not an independent risk factor for hepatocellular carcinoma.
Tseng CH
Diabetes Metab Res Rev; 2013 Oct; 29(7):515-24. PubMed ID: 23658071
[TBL] [Abstract][Full Text] [Related]
15. Thyroid cancer risk is not increased in diabetic patients.
Tseng CH
PLoS One; 2012; 7(12):e53096. PubMed ID: 23300866
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone does not affect the risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Metabolism; 2014 Aug; 63(8):1049-55. PubMed ID: 24889868
[TBL] [Abstract][Full Text] [Related]
17. Lifetime physical activity and the risk of breast cancer: a case-control study.
Kruk J
Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272
[TBL] [Abstract][Full Text] [Related]
18. Oral cancer in Taiwan: is diabetes a risk factor?
Tseng CH
Clin Oral Investig; 2013 Jun; 17(5):1357-64. PubMed ID: 22895832
[TBL] [Abstract][Full Text] [Related]
19. Diabetes and thyroid cancer mortality: a 12-year prospective follow-up of Taiwanese.
Tseng CH
Eur J Clin Invest; 2013 Jun; 43(6):595-601. PubMed ID: 23550697
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
